Literature DB >> 25576388

A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort.

M Srinivas1, Vijaya Srinivasan, Madhu Bashini Mohan, Joy Varghese, Jayanthi Venkataraman.   

Abstract

BACKGROUND: Metabolic syndrome (MS) is associated with fatty liver (FL) disease. Gender differences in this association are not known. AIM: The aim of the present study was to determine gender-wise association between FL and MS components (using Asia-Pacific guidelines 2007) in an urban south Indian cohort with normal liver function tests (LFT).
METHODS: Records of consecutive attendees of a Master Health Check up program were reviewed for age, gender, body mass index (BMI), blood pressure, fasting blood sugar (FBS), high-density lipoproteins, triglyceride (TG) levels, presence of FL by ultrasound. The cohort was grouped gender-wise as FL and nonfatty liver (NFL). Foreign nationals; those with alcohol intake >20 g/day; and those with diabetes, hypertension, hypertriglyceridemia, chronic liver disease, or abnormal LFT were excluded. STATISTICS: Chi-square, gender-wise univariate and logistic regression analyses of each MS component for FL, relative risk (RR), and 95 % confidence interval (CI) for significant factors (p < 0.05 and RR or log odds >1.5) were calculated.
RESULTS: Of the 1,075 (63 % males) cases included, 45.8 % had FL. Gender (log odds 1.6 compared to women) and BMI ≥25 kg/m(2) (RR 1.6 % to 95 % CI 1.3 to 1.9; log odds 2.2) were the only factors associated with FL in men. In women, age ≥40 years (log odds 2.3), fasting blood sugar (FBS) ≥100 mg/dL (RR 1.8-1.4 to 2.3; log odds 1.9), and TG ≥150 mg/dL (RR 1.7-1.3 to 2.1; log odds 1.7) were independently associated with FL.
CONCLUSION: There was a gender-wise difference in MS components associated with hepatic steatosis and normal LFT in a south Indian urban cohort.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25576388     DOI: 10.1007/s12664-014-0525-4

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  25 in total

Review 1.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.

Authors:  Kaushal Madan; Yogesh Batra; S Datta Gupta; Bal Chander; K D Anand Rajan; M S Tewatia; S K Panda; S K Acharya
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 3.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

4.  Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast.

Authors:  Y Yajima; K Ohta; T Narui; R Abe; H Suzuki; M Ohtsuki
Journal:  Tohoku J Exp Med       Date:  1983-01       Impact factor: 1.848

5.  Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.

Authors:  Ji Young Lee; Kang Mo Kim; Sung Gyu Lee; Eunsil Yu; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong-Jin Suh
Journal:  J Hepatol       Date:  2007-03-06       Impact factor: 25.083

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.

Authors:  Chalamalasetty Sreenivasa Baba; George Alexander; Bikkasani Kalyani; Rakesh Pandey; Sujata Rastogi; Amaresh Pandey; Gourdas Choudhuri
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

Review 8.  Nonalcoholic steatohepatitis.

Authors:  S G Sheth; F D Gordon; S Chopra
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

9.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

10.  Prevalence of non-alcoholic fatty liver disease: population based study.

Authors:  Deepak Amarapurkar; Prafull Kamani; Nikhil Patel; Parijat Gupte; Pravin Kumar; Subhash Agal; Rajiv Baijal; Somesh Lala; Dinesh Chaudhary; Anjali Deshpande
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

View more
  1 in total

1.  Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Authors:  Anshuman Elhence; Bhavik Bansal; Hardik Gupta; Abhinav Anand; Thakur P Singh; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.